المؤلفون: N Harbeck, H Zhang, CH Barrios, S Saji, KH Jung, R Hegg, A Köhler, J Sohn, H Iwata, ML Telli, C Ferrario, K Punie, F Penault-Llorca, S Patel, A Nguyen Duc, M Liste-Hermoso, V Maiya, L Molinero, SY Chui, EA Mittendorf

المصدر: Senologie - Zeitschrift für Mammadiagnostik und -therapie.

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Quality of life, Atezolizumab, business.industry, Internal medicine, medicine, Stage (cooking), business, Triple-negative breast cancer

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9ac4ddd6d143fa42599306945920f73a
https://doi.org/10.1055/s-0041-1730167

المؤلفون: Sarah S. Murray, Deirdre O'Sullivan, Ali Torkamani, Mihaela Lorger, ML Telli, A Fernandez-Santidrian, SV Vaughn, H Cunliffe, Julie Steele, Dhara MacDermed, Brunhilde Felding-Habermann, SS Jeffrey

المصدر: Cancer Research. 71:PD03-07

مصطلحات موضوعية: CA15-3, Cancer Research, Pathology, medicine.medical_specialty, Bevacizumab, business.industry, Cancer, medicine.disease, Inflammatory breast cancer, Primary tumor, Metastasis, Breast cancer, Oncology, medicine, Cancer research, Malignant pleural effusion, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c43baf0065bd2c6bb5ad7cd140007e19
https://doi.org/10.1158/0008-5472.sabcs11-pd03-07

المؤلفون: Telli ML; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. mtelli@stanford.edu., Litton JK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Beck JT; Department of Medical Oncology and Hematology, Highlands Oncology, Springdale, AR, USA., Jones JM; Avera Medical Group Oncology & Hematology, Avera Cancer Institute, Sioux Falls, SD, USA., Andersen J; Medical Oncology, Compass Oncology, West Cancer Center, US Oncology Network, Tigard, OR, USA., Mina LA; Hematology Oncology Department, Banner MD Anderson Cancer Center, Gilbert, AZ, USA., Brig R; Medical Oncology, Brig Center for Cancer Care and Survivorship, Knoxville, TN, USA., Danso M; Medical Oncology, Virginia Oncology Associates, Norfolk, VA, USA., Yuan Y; Department of Medical Oncology & Therapeutics Research, Cedars-Sinai Cancer Center, West Hollywood, CA, USA., Symmans WF; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hopkins JF; Foundation Medicine, Inc., Cambridge, MA, USA., Albacker LA; Foundation Medicine, Inc., Cambridge, MA, USA., Abbattista A; Clinical Statistics, Pfizer Oncology, Milan, Italy., Noonan K; Clinical Oncology, Pfizer Inc., Groton, CT, USA., Mata M; Pfizer Inc., La Jolla, CA, USA., Laird AD; Pfizer Inc., South San Franciso, CA, USA., Blum JL; Department of Oncology, Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas, TX, USA.

المصدر: Breast cancer (Tokyo, Japan) [Breast Cancer] 2024 Sep; Vol. 31 (5), pp. 886-897. Date of Electronic Publication: 2024 Jun 13.

نوع المنشور: Journal Article; Clinical Trial, Phase II

بيانات الدورية: Publisher: Maruzen Co Country of Publication: Japan NLM ID: 100888201 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1880-4233 (Electronic) Linking ISSN: 13406868 NLM ISO Abbreviation: Breast Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Triple Negative Breast Neoplasms*/genetics , Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/pathology , Germ-Line Mutation* , Phthalazines*/therapeutic use , Phthalazines*/administration & dosage , BRCA2 Protein*/genetics , BRCA1 Protein*/genetics , Neoadjuvant Therapy*/methods, Humans ; Female ; Middle Aged ; Retrospective Studies ; Adult ; Biomarkers, Tumor/genetics ; Aged ; Loss of Heterozygosity

المؤلفون: Gradishar WJ; Robert H . Lurie Comprehensive Cancer Center of Northwestern University., Moran MS; Yale Cancer Center/Smilow Cancer Hospital., Abraham J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Abramson V; Vanderbilt-Ingram Cancer Center., Aft R; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine., Agnese D; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Allison KH; Stanford Cancer Institute., Anderson B; University of Wisconsin Carbone Cancer Center., Bailey J; University of Michigan Rogel Cancer Center., Burstein HJ; Dana-Farber/Brigham and Women's Cancer Center., Chen N; The UChicago Medicine Comprehensive Cancer Center., Chew H; UC Davis Comprehensive Cancer Center., Dang C; Memorial Sloan Kettering Cancer Center., Elias AD; University of Colorado Cancer Center., Giordano SH; The University of Texas MD Anderson Cancer Center., Goetz MP; Mayo Clinic Comprehensive Cancer Center., Jankowitz RC; Abramson Cancer Center at the University of Pennsylvania., Javid SH; Fred Hutchinson Cancer Center., Krishnamurthy J; Fred & Pamela Buffett Cancer Center., Leitch AM; UT Southwestern Simmons Comprehensive Cancer Center., Lyons J; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., McCloskey S; UCLA Jonsson Comprehensive Cancer Center., McShane M; Fox Chase Cancer Center., Mortimer J; City of Hope National Medical Center., Patel SA; Fox Chase Cancer Center., Rosenberger LH; Duke Cancer Institute., Rugo HS; UCSF Helen Diller Family Comprehensive Cancer Center., Santa-Maria C; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins., Schneider BP; Indiana University Melvin and Bren Simon Comprehensive Cancer Center., Smith ML; Research Advocacy Network., Soliman H; Moffitt Cancer Center., Stringer-Reasor EM; O'Neal Comprehensive Cancer Center at UAB., Telli ML; Stanford Cancer Institute., Wei M; Huntsman Cancer Institute at the University of Utah., Wisinski KB; University of Wisconsin Carbone Cancer Center., Yeung KT; UC San Diego Moores Cancer Center., Young JS; Roswell Park Comprehensive Cancer Center., Schonfeld R; National Comprehensive Cancer Network., Kumar R; National Comprehensive Cancer Network.

المصدر: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2024 Jul; Vol. 22 (5), pp. 331-357.

نوع المنشور: Journal Article; Practice Guideline

بيانات الدورية: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/therapy , Breast Neoplasms*/diagnosis , Breast Neoplasms*/pathology, Humans ; Female ; Medical Oncology/standards ; Medical Oncology/methods ; Combined Modality Therapy/standards

المؤلفون: Ransohoff JD; Department of Medicine (Oncology), Stanford University School of Medicine, Palo Alto, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Palo Alto, CA, USA., Miller I; Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA., Koo J; Stanford Cancer Institute, Stanford University School of Medicine, Palo Alto, CA, USA., Joshi V; Department of Medicine (Oncology), Stanford University School of Medicine, Palo Alto, CA, USA., Kurian AW; Department of Medicine (Oncology), Stanford University School of Medicine, Palo Alto, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Palo Alto, CA, USA.; Department of Epidemiology and Population Health, Stanford University School of Medicine, Palo Alto, CA, USA., Allison KH; Stanford Cancer Institute, Stanford University School of Medicine, Palo Alto, CA, USA.; Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA., John EM; Department of Medicine (Oncology), Stanford University School of Medicine, Palo Alto, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Palo Alto, CA, USA.; Department of Epidemiology and Population Health, Stanford University School of Medicine, Palo Alto, CA, USA., Telli ML; Department of Medicine (Oncology), Stanford University School of Medicine, Palo Alto, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Palo Alto, CA, USA.; Department of Epidemiology and Population Health, Stanford University School of Medicine, Palo Alto, CA, USA.

المصدر: JNCI cancer spectrum [JNCI Cancer Spectr] 2024 Feb 29; Vol. 8 (2).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print Cited Medium: Internet ISSN: 2515-5091 (Electronic) Linking ISSN: 25155091 NLM ISO Abbreviation: JNCI Cancer Spectr Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology, Humans ; Female ; Lymphocytes, Tumor-Infiltrating ; Prognosis ; California/epidemiology ; Registries

المؤلفون: Zhang M; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA., Venkateshappa R; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA., Li A; Greenstone Bioscience, Palo Alto, CA 94304, USA., Fowler MB; Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA., Telli ML; Department of Medicine, Division of Medical Oncology, Stanford University, Stanford, CA 94305, USA., Wu JC; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: joewu@stanford.edu.

المصدر: Stem cell research [Stem Cell Res] 2023 Dec; Vol. 73, pp. 103246. Date of Electronic Publication: 2023 Nov 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101316957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-7753 (Electronic) Linking ISSN: 18735061 NLM ISO Abbreviation: Stem Cell Res Subsets: MEDLINE

مواضيع طبية MeSH: Induced Pluripotent Stem Cells*/metabolism , Breast Neoplasms*/genetics, Humans ; Female ; Leukocytes, Mononuclear/metabolism ; Mutation/genetics ; Germ-Line Mutation ; Ataxia Telangiectasia Mutated Proteins/genetics

المؤلفون: Lenz L; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Neff C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Solimeno C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Cogan ES; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Abramson VG; Vanderbilt University Medical Center, Nashville, TN, USA., Boughey JC; Mayo Clinic, Rochester, MN, USA., Falkson C; University of Rochester Medical Center, Rochester, NY, USA., Goetz MP; Mayo Clinic, Rochester, MN, USA., Ford JM; Stanford University School of Medicine, Stanford, CA, USA., Gradishar WJ; Northwestern University, Chicago, IL, USA., Jankowitz RC; University of Pennsylvania, Philadelphia, PA, USA., Kaklamani VG; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Marcom PK; Duke University, Durham, NC, USA., Richardson AL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Storniolo AM; Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA., Tung NM; Beth Israel Deaconess Medical Center, Boston, MA, USA., Vinayak S; University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, 15. AstraZeneca, Seattle, WA, USA., Hodgson DR; AstraZeneca, Cambridge, UK., Lai Z; AstraZeneca, Boston, MA, USA., Dearden S; AstraZeneca, Cambridge, UK., Hennessy BT; Royal College of Surgeons in Ireland, Dublin, Ireland., Mayer EL; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mills GB; Oregon Health & Science University, Portland, OR, USA., Slavin TP; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Gutin A; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Connolly RM; Cancer Research @UCC, University College Cork, Cork, Ireland., Telli ML; Stanford University School of Medicine, Stanford, CA, USA., Stearns V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Lanchbury JS; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Timms KM; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA. ktimms@myriad.com.

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Nov; Vol. 202 (1), pp. 191-201. Date of Electronic Publication: 2023 Aug 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/epidemiology , Triple Negative Breast Neoplasms*/genetics , Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/epidemiology , Ovarian Neoplasms*/genetics, Humans ; Female ; BRCA1 Protein/genetics ; Platinum ; BRCA2 Protein/genetics ; Genomic Instability ; Homologous Recombination

المؤلفون: Turner NC; The Royal Marsden Hospital, The Institute of Cancer Research, London, UK. Nicholas.Turner@icr.ac.uk., Laird AD; Pfizer Inc., La Jolla, CA, USA., Telli ML; Stanford University School of Medicine, Stanford, CA, USA., Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Mailliez A; Department of Medical Oncology, Breast Cancer Unit, Centre Oscar Lambret, Lille, France., Ettl J; Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany., Grischke EM; Universitӓts Frauenklinik Tübingen, Eberhard Karls University, Tübingen, Germany., Mina LA; Banner MD Anderson Cancer Center, Gilbert, AZ, USA., Balmaña J; Hospital Vall d'Hebron, and Vall d'Hebron Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain., Fasching PA; University Hospital Erlangen, Department of Gynecology and Obstetrics, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Hurvitz SA; University of California, Los Angeles/Jonsson Comprehensive Cancer Center (UCLA/JCCC), Los Angeles, CA, USA., Hopkins JF; Foundation Medicine Inc., Cambridge, MA, USA., Albacker LA; Foundation Medicine Inc., Cambridge, MA, USA., Chelliserry J; Pfizer Inc., La Jolla, CA, USA., Chen Y; Pfizer Inc., La Jolla, CA, USA., Conte U; Pfizer Inc., New York, NY, USA., Wardley AM; Manchester Breast Centre, Division of Cancer Sciences, University of Manchester, Manchester, UK., Robson ME; Memorial Sloan Kettering Cancer Center, New York, NY, USA.

المصدر: NPJ breast cancer [NPJ Breast Cancer] 2023 Oct 06; Vol. 9 (1), pp. 81. Date of Electronic Publication: 2023 Oct 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

المؤلفون: Litton JK; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Beck JT; Department of Medical Oncology and Hematology, Highlands Oncology, Springdale, AR, USA., Jones JM; Avera Medical Group Oncology & Hematology, Avera Cancer Institute, Sioux Falls, SD, USA., Andersen J; Medical Oncology, Compass Oncology, West Cancer Center, US Oncology Network, Tigard, OR, USA., Blum JL; Department of Oncology, Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas, TX, USA., Mina LA; Hematology Oncology Department, Banner MD Anderson Cancer Center, Gilbert, AZ, USA., Brig R; Medical Oncology, Brig Center for Cancer Care and Survivorship, Knoxville, TN, USA., Danso M; Medical Oncology, Virginia Oncology Associates, Norfolk, VA, USA., Yuan Y; Department of Medical Oncology & Therapeutics Research, Cedars-Sinai Cancer Center, West Hollywood, CA, USA., Abbattista A; Clinical Statistics, Pfizer Oncology, Milan, Italy., Noonan K; Clinical Oncology, Pfizer Inc., Groton, CT, USA., Niyazov A; Oncology Value & Evidence, Pfizer Inc., New York, NY, USA., Chakrabarti J; Medical Oncology, Pfizer Ltd., Walton Oaks, Surrey, UK., Czibere A; Oncology Drug Development, Pfizer Inc., Cambridge, MA, USA., Symmans WF; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Telli ML; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

المصدر: The oncologist [Oncologist] 2023 Oct 03; Vol. 28 (10), pp. 845-855.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: BRCA1 Protein*/genetics , Triple Negative Breast Neoplasms*/drug therapy , Triple Negative Breast Neoplasms*/genetics, Humans ; Neoadjuvant Therapy ; BRCA2 Protein/genetics ; Quality of Life ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Poly(ADP-ribose) Polymerase Inhibitors/adverse effects ; Germ-Line Mutation ; Anthracyclines/therapeutic use

المؤلفون: Zhang M; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA., Liu W; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA., Li A; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA., Htet MH; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA., Yu R; Greenstone Bioscience, Palo Alto, CA 94304, USA., Telli ML; Department of Medicine, Division of Medical Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA., Wu JC; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Medicine, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: joewu@stanford.edu.

المصدر: Stem cell research [Stem Cell Res] 2023 Oct; Vol. 72, pp. 103219. Date of Electronic Publication: 2023 Oct 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101316957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-7753 (Electronic) Linking ISSN: 18735061 NLM ISO Abbreviation: Stem Cell Res Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Induced Pluripotent Stem Cells*/metabolism, Humans ; Female ; Genes, BRCA2 ; Germ-Line Mutation ; Mutation ; BRCA2 Protein/genetics ; BRCA2 Protein/metabolism